Superior Performance of FN® Coatings(photocatalytic multifunctional nano coatings)

MEDICAL APPLICATIONS

Apply in …• Living rooms, bedrooms,

kids rooms • Kitchens and bathrooms• Hotels, spas, restaurants

and cafeterias• Schools and nurseries • Hospitals and clinics• Offices and public areas

And say „no more“ to …• Headaches, lethargy, fatigue,

and poor concentration • Respiratory illnesses and

asthmas • Allergies and skin irritations• Virus and bacteria dispersion• Unpleasant odors, molds and

dirt on walls

FN® Coatings

MRSA

WHY FN® COATINGS IN HOSPITALS AND MEDICAL FACILITIES?

NOSOCOMIAL INFECTIONS

OVEREXPOSURE TO DISINFECTIONS AND CHEMICALS

INFECTIONS OUTBREAKS

PATIENT AND PERSONNEL PROTECTIONSANITARY AND CLEAN ENVIRONMENT

INFECTIONS OUTBREAK CONTROL

FAST REMOVAL OF EXCESS OF DISINFECTION AND CHEMICALS

INFECTION OUTBREAK

INFECTION OUTBREAK CONTROLSOFT UVA ACTIVATION LIGHTS ON!!!

THE AIR IS CLEAN IN ABOUT 1-2 HOURS

• VIRUS CONCENTRATION STABILIZED UNDER THE INFECTION CRITICAL LEVEL

• INFECTION LOCALIZED

FN® COATING

FN® ANTIMICROBIAL FUNCTION WAS PROVEN BY SEVERAL ACCREDITED LABS AND IN MANY PRACTICAL APPLICATIONS

15 min 30 min

FN2 FN2Non active Non active

MicroorganismUV Exposure

UV Intensity

START concentration

END concentration

Reference sample END

concentration

BACTERIA REDUCTION ON

FN2 SURFACEtime (min) mW/cm2 (CFU) (CFU) (CFU) (%)

0.2 mlBakteriofag E.Coli ΦX 174 60 min 0.05-0.1 1.00E+06 60 1.00E+06 99.9940%(MODEL VIRUS) 60 min 0.05-0.1 1.00E+06 30 1.00E+06 99.9970%

6 hours 0.05-0.1 1.00E+08 88 1.00E+08 99.9999%6 hours 0.05-0.1 1.00E+05 0 1.00E+05 100%6 hours 0.05-0.1 1.00E+08 400 1.00E+08 99.9996%6 hours 0.05-0.1 1.00E+05 15 1.00E+05 99.9850%60 min 0-dark 1.00E+06 1.00E+06 1.00E+06 0%

0.2 mlCandida albicans 120 min 0.05-0.1 1.00E+06 0 1.00E+06 100%Candida albicans 120 min 0.05-0.1 1.00E+06 0 1.00E+06 100%

0.2 ml Pseudomonas aeruginosa 120 min 0.05-0.1 1.00E+06 0 1.00E+06 100%Pseudomonas aeruginosa 120 min 0.05-0.1 1.00E+06 0 1.00E+06 100%

0.3 mlEnterococcus faecalis 4224 120 min 0.1-0.3 1.50E+08 767 not countable 99.99949%

PUBLIC HEALTH PROTECTION

VERY EFFICIENT NON-CHEMICAL SANITARY FUNCTION

• HOSPITALS• MEDICAL CENTERS• BIOLABS• OFFICES• SCHOOLS• KINDERGARTENS• BANKS• PUBLIC BUILDINGS• TRAIN/BUS STATIONS• AIRPORTS

MicroorganismUV Exposure

UV Intensity

START concentration

END concentration

Reference sample END

concentration

BACTERIA REDUCTION ON

FN2 SURFACEtime (min) mW/cm2 (CFU) (CFU) (CFU) (%)

0.2 mlBakteriofag E.Coli ΦX 174 60 min 0.05-0.1 1.00E+06 60 1.00E+06 99.9940%(MODEL VIRUS) 60 min 0.05-0.1 1.00E+06 30 1.00E+06 99.9970%

6 hours 0.05-0.1 1.00E+08 88 1.00E+08 99.9999%6 hours 0.05-0.1 1.00E+05 0 1.00E+05 100%6 hours 0.05-0.1 1.00E+08 400 1.00E+08 99.9996%6 hours 0.05-0.1 1.00E+05 15 1.00E+05 99.9850%60 min 0-dark 1.00E+06 1.00E+06 1.00E+06 0%

0.2 mlCandida albicans 120 min 0.05-0.1 1.00E+06 0 1.00E+06 100%Candida albicans 120 min 0.05-0.1 1.00E+06 0 1.00E+06 100%

0.2 ml Pseudomonas aeruginosa 120 min 0.05-0.1 1.00E+06 0 1.00E+06 100%Pseudomonas aeruginosa 120 min 0.05-0.1 1.00E+06 0 1.00E+06 100%

0.3 mlEnterococcus faecalis 4224 120 min 0.1-0.3 1.50E+08 767 not countable 99.99949%

Yeast fungi: Candida albicans can cause serious and potentially life-threatening infections in the mouth, blood and other tissues of people who are undergoing cancer chemotherapy or radiation treatments, or who have developed AIDS or other diseases that damage the immunity of the individual.

Image courtesy of http://www.chuv.ch/

Pseudomonas aeruginosa

Candida albicans

Pseudomonas aeruginosa has become an important cause of infection, especially in patients with compromised host defense mechanisms. It is the most common pathogen isolated from patients who have been hospitalized longer than 1 week. It is a frequent cause of nosocomial infections such as pneumonia, urinary tract infections (UTIs), and bacteremia. Pseudomonal infections are complicated and can be life threatening.

Enterococcus faecalis

E. faecalis can cause life-threatening infections in humans, especially in the nosocomial(hospital) environment, where the naturally high levels of antibiotic resistance found in E. faecalis contribute to its pathogenicity.[1] E. faecalis has been frequently found in root canal-treated teeth.

Microorganism Exposure UV UV IntensitySTART

concentrationEND

concentration Reference sample

END concentration Bacteria reduction

on FN2 surface(FN2 Protocol #) time (min) mW/cm2 (CFU) (CFU) (CFU) (%)Stapthylococcus aureus CCM 3953 0.2 ml 1734/2010 H4 60 0.05-0.1 1.20E+08 100 7.50E+05 99.9999%1474/2010 P4 60 0.05-0.1 1.20E+08 150 7.50E+05 99.9999%1470/2010 P3 60 0.05-0.1 1.20E+08 100 7.50E+05 99.9999%1473/2010 H4 60 0.05-0.1 1.20E+08 100 7.50E+05 99.9999%1472/2010 H3 60 0.05-0.1 1.30E+08 100 7.50E+05 99.9999%FN2 A 60 0.05-0.1 3.45E+07 250 1.10E+06 99.9993%FN2 B 60 0.05-0.1 3.45E+07 250 1.10E+06 99.9993%FN2 C 60 0.05-0.1 3.45E+07 250 1.10E+06 99.9993%

Stapthylococcus aureus ATCC 33591 0.35 mlFN2-P1 80 NA 1.00E+05 0 NA 100%FN2-P2 80 NA 1.00E+05 0 NA 100%

Staphylococcus aureus CCM 3953 0.3 mlprints on agar 120 0.1-0.3 1.80E+08 34 not countable 99.99998%

Stapthylococus aureus 0.1 mlPP-FN2 tab 67 120 0.05-0.1 1.65E+09 34 1.00E+04 99.999998%FN2 tab 61 300 0.05-0.1 1.00E+06 250 1.00E+06 99.975000%FN2 DARK tab 42 120 dark 1.00E+06 1.00E+06 1.00E+06 0%

FN®:•PROVIDES HELPFUL PROTECTION TO CHILDREN AND OTHER PATIENTS ON CHEMOTHERAPY•PREVENTION OF INFFECTION OUTBREAKS

FN®:• BIOCIDIDE EFFICACY • NO CHEMISTRY-PHYSICAL EFFECT (2011 REMOVED FROM BIOCIDE LEGISLATION IN EU)

MRSA is a serious hospital acquired infection, which is a form of the Staphylococcus bacterium resistant to the commonly used antibiotic methicillin. http://www.direct-healthcare.com/mrsa.htm

Proportionally, 50% reduction of MRSA in the USA means:

Saving life to 12,500 people Saving post operation problems to

250,000 people Reduction of economical losses ~ $ 4bn

FN Coatings are an excellent prevention of MRSA.No release of chemicals into the environment!!!

Hospital Acquired Infections cost the NHS around £1bn per annum, affect some 100,000 patients a year and is responsible for the deaths of around 5,000 patients annually in the UK.……. alarming rate with some hospitals reporting secondary infection rates as high as 20%.

FN® COATINGS – NO CHEMISTRY INVOLVED FN® COATINGS ARE EXTREMELY EFFICIENT IN “BURNING”

MICROORGANISMS ON THEIR HIGHLY OXIDATIVE SURFACE

THE PHOTOCATALYTIC ACTION IS AS STRONG AS USING POISONOUS CHEMICALS, WHILE IT IS PROVIDED SOLELY BY THE TiO2 PHYSICAL EFFECT OF PHOTOCATALYSIS, WHITH NO CHEMISTRY INVOLVED

TiO2 IS COMPLETELY INERT, SAFE AND UNREGULATED COMPOUND

WALLS AND CEILING PAINTED BY FN® COATINGS ARE A GREAT MICROBIAL PREVENTION AND A WAY, HOW TO CREATE CLEAN AND SANITARY ENVIRONMENT WITHOUT ANY CHEMICALS INVOLVED

FN® COATINGS ARE INERT AND PERFECTLY COMPACTIBLE WITH ALL CHEMICALS AND DISINFECTING AGENTS.

GIC

PRACTICAL INSTALLATION DIFFERS ONLY SLIGHTLY FROM REGULAR PAINTING

result

UVA ACTIVATION LIGHT

DAYLIGHT – MAIN SOURCE OF THE ACTIVATION ENERGY

CEILINGS – FN3® COATING

WALLS– FN2® COATING

SOFT UVA ACTIVATION LAMPS INSTALLED FOR DARK DAYS, NIGHT AND CRITICAL SITUATIONS SUCH AS INFECTION OUTBREAKS, ODOR PROBLEMS, ETC,…

Internal Medicine Hospital

USEFUL UNIVERSALLY

Fitness centersWarehouses

PHARMACY STORES

WAITING ROOMS

CHILDREN’S ONCOLOGY

Dental clinique

YESTERDAY UNKNOWN

TODAY AN OPTION

TOMORROW A STANDARD

BREATH SAFE AIR

Eye Clinique